Active ingredient : Eribulin Eribulin
HALAVEN INJECTION is an innovative medication designed for the treatment of specific types of cancer. Utilizing the active ingredient Eribulin, this product is formulated to help manage and inhibit the growth of cancer cells effectively.
Couldn't load pickup availability
Free shipping and returns available on all orders!
We ship all US domestic orders within 5-10 business days
HALAVEN (Eribulin) is a chemotherapy medication used to treat certain types of breast cancer. It is administered via injection and works by inhibiting cancer cell growth and division.
The recommended dosage of HALAVEN is typically 1.4 mg/m² administered as an intravenous infusion on days 1 and 8 of a 21-day treatment cycle. Always follow your healthcare provider's instructions regarding dosage and administration.
Common side effects may include:
Consult your healthcare provider if you experience severe side effects or have concerns during treatment.
HALAVEN is primarily used to treat patients with metastatic breast cancer.
HALAVEN is given as an intravenous infusion by a healthcare professional.
If you miss a dose, contact your healthcare provider for guidance on how to proceed.
HALAVEN may be used in combination with other cancer treatments, but this should be discussed with your healthcare provider.